NCT00388986View on ClinicalTrials.gov

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

GK Activator (2)

100mg po bid

DRUG

Glyburide

10-20mg po daily

Trial Locations (4)

78229

San Antonio

90630

Cypress

96813

Honolulu

NY 14215

Buffalo

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00388986 - A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. | Biotech Hunter | Biotech Hunter